Dyslipidemias
372
43
61
216
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Published Results
43 trials with published results (12%)
Research Maturity
216 completed trials (58% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.7%
10 terminated out of 372 trials
95.6%
+9.1% vs benchmark
20%
74 trials in Phase 3/4
20%
43 of 216 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 216 completed trials
Clinical Trials (372)
Nudging Preventive Screening Via Message Framing and Bundling
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MWX205
Uppsala Self-Screening of Cardiovascular Health (U-SCREEN)
A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia
Study of ARO-APOC3 in Adults With Dyslipidemia
Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease
Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
Psychosocial, Environmental, and Chronic Disease Trends in Puerto Rico
Impact of Phytosterol-Rich Extract on Lipid Profile
Dose Response Effects of Pecan Consumption
Cottonseed Oil Dose Response
Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa
Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
Efficacy of Low-dose (10 mg) Rosuvastatin in Korean 4 Statin Benefit Groups Per 2013 ACC/AHA Guideline
Pilot Validation of the STELA Preventive Medicine Platform to Reduce Modifiable Health Risk Factors in Adults (CPM-STELA)
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
Group Medical Visits for Patients With Dyslipidemia
Cluster Randomized Trial of a Digital Quality Improvement Intervention on LDLCholesterol Control
The Bialystok Bariatric Surgery Study